News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Allergan Inc. (AGN) Will Aggressively Cut Costs, Review Pipeline To Ward Off Valeant Pharmaceuticals International (VRX)


7/9/2014 7:20:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Allergan Inc. (AGN:US), the Botox maker being pursued by Valeant Pharmaceuticals International Inc. and Bill Ackman’s hedge fund, will shelve unpromising pipeline drugs and overhaul management incentives, two people with knowledge of the matter said.

A broad restructuring plan set to be outlined during Allergan’s earnings (AGN:US) announcement later this month will also involve companywide cost cuts, including some legacy expenses, said the people, who asked not to be identified because the effort isn’t yet public. Management compensation will be more closely tied to achieving higher forecasts.

Help employers find you! Check out all the jobs and post your resume.

Read at Business Week
Read at News Release
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES